Headillu

European Society of Cardiology Congress (ESC)

Background information for medical media outside the US only

Disclaimer

The content of the website has been cleared by Boehringer Ingelheim GmbH in compliance with the legal provisions applicable for German companies. Such provisions vary from country to country and can have an impact on the information we can provide to you.

Thus, please contact us directly in case further information is requested which takes into account the framework in your home country.

contact

30 August - 3 September 2008

The TRANSCEND® Trial Results

ESC Congress 2008
Media event:

The ESC congress provides a forum offering the opportunity to meet and exchange ideas and information in the field of cardiovascular medicine.

Venue:
Live webcast:

Available as of 31 August 2008

Potential implications of the ONTARGET® Trial Programme

Join TRANSCEND® investigator Professor Peter Sleight as he presents the results of the TRANSCEND® Trial and, along with other experts, discusses the potential implications of the ONTARGET® Trial Programme for clinical practice.

Media contact

  • Boehringer Ingelheim GmbH

    Corporate Division Communications
    Dr Reinhard Malin
    55216 Ingelheim
    Germany

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed